- Home
- EXEL vs INFA Comparison
EXEL vs INFA Comparison
Compare EXEL & INFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- INFA
- Stock Information
- Founded
- EXEL 1994
- INFA 1993
- Country
- EXEL United States
- INFA United States
- Employees
- EXEL N/A
- INFA N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- INFA EDP Services
- Sector
- EXEL Health Care
- INFA Technology
- Exchange
- EXEL Nasdaq
- INFA Nasdaq
- Market Cap
- EXEL 9.7B
- INFA 8.1B
- IPO Year
- EXEL 2000
- INFA 2021
- Fundamental
- Price
- EXEL $34.45
- INFA $24.79
- Analyst Decision
- EXEL Buy
- INFA Buy
- Analyst Count
- EXEL 18
- INFA 12
- Target Price
- EXEL $31.72
- INFA $33.00
- AVG Volume (30 Days)
- EXEL 2.6M
- INFA 2.4M
- Earning Date
- EXEL 10-29-2024
- INFA 10-30-2024
- Dividend Yield
- EXEL N/A
- INFA N/A
- EPS Growth
- EXEL 441.02
- INFA N/A
- EPS
- EXEL 1.55
- INFA 0.21
- Revenue
- EXEL $2,081,598,000.00
- INFA $1,656,891,000.00
- Revenue This Year
- EXEL $20.53
- INFA $6.76
- Revenue Next Year
- EXEL $1.54
- INFA $7.11
- P/E Ratio
- EXEL $22.26
- INFA $116.50
- Revenue Growth
- EXEL 17.31
- INFA 6.98
- 52 Week Low
- EXEL $19.20
- INFA $22.08
- 52 Week High
- EXEL $36.60
- INFA $39.80
- Technical
- Relative Strength Index (RSI)
- EXEL 67.10
- INFA 43.13
- Support Level
- EXEL $27.86
- INFA $24.06
- Resistance Level
- EXEL $36.49
- INFA $25.75
- Average True Range (ATR)
- EXEL 0.98
- INFA 0.94
- MACD
- EXEL -0.01
- INFA -0.21
- Stochastic Oscillator
- EXEL 74.10
- INFA 17.89
About EXEL Exelixis Inc.
Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About INFA Informatica Inc.
Informatica Inc is a pioneered new category of software, the Intelligent Data Management Cloud, or IDMC. IDMC is an AI-powered platform that connects, manages, and unifies data across any multi-cloud, hybrid system, empowering enterprises to modernize and advance data strategies.